AMPD1 is the skeletal-muscle ("M") isoform of AMP deaminase, a cytosolic zinc metalloenzyme that catalyses the hydrolytic deamination of AMP to IMP and ammonia (AMP + H2O -> IMP + NH4+; EC 3.5.4.6). It is a homotetramer of the metallo-dependent hydrolase superfamily (adenosine and AMP deaminase family). In skeletal muscle AMPD1 performs the committed step of the purine nucleotide cycle (AMP -> IMP by AMP deaminase; IMP -> adenylosuccinate by adenylosuccinate synthase; adenylosuccinate -> AMP + fumarate by adenylosuccinate lyase). By deaminating AMP, the enzyme pulls the adenylate kinase equilibrium toward ATP regeneration and thereby buffers the cellular energy charge during intense exercise, while the cycle also releases fumarate for TCA-cycle anaplerosis and ammonia. It is the most highly expressed AMP deaminase isoform in skeletal muscle (also expressed in tongue). Loss-of-function of AMPD1 causes myoadenylate deaminase deficiency (AMP deaminase deficiency; MMDD, MIM:615511), one of the most common inherited metabolic muscle defects, which is frequently benign or asymptomatic but can present with exercise-induced myalgia, cramps and early fatigue.
| GO Term | Evidence | Action | Reason |
|---|---|---|---|
|
GO:0003876
AMP deaminase activity
|
IBA
GO_REF:0000033 |
ACCEPT |
Summary: Core molecular function. AMPD1 hydrolytically deaminates AMP to IMP plus ammonia (EC 3.5.4.6), the defining and experimentally established activity of this enzyme. The phylogenetic (IBA) call is well supported and consistent with direct human evidence.
Reason: AMP deaminase activity is the primary, catalytically demonstrated function of AMPD1. UniProt records the reaction and EC number with experimental evidence, and disease-causing mutations abolish this activity.
Supporting Evidence:
file:human/AMPD1/AMPD1-uniprot.txt
Reaction=AMP + H2O + H(+) = IMP + NH4(+)
PMID:11102975
undetectable AMPD activity in the
|
|
GO:0006188
IMP biosynthetic process
|
IBA
GO_REF:0000033 |
KEEP AS NON CORE |
Summary: IMP is the direct product of AMPD1-catalysed AMP deamination, so participation in IMP biosynthesis is correct. UniProt frames the pathway as "IMP biosynthesis via salvage pathway; IMP from AMP: step 1/1", which is captured more precisely by GO:0032264 IMP salvage.
Reason: Accurate but less precise than the salvage-specific term; retained as a correct broader process annotation rather than the core process framing.
Supporting Evidence:
file:human/AMPD1/AMPD1-uniprot.txt
Purine metabolism; IMP biosynthesis via salvage pathway
|
|
GO:0046033
AMP metabolic process
|
IBA
GO_REF:0000033 |
ACCEPT |
Summary: AMPD1 acts directly on AMP (its substrate), so participation in AMP metabolic process is accurate and reflects the enzyme's role in the purine nucleotide cycle and adenylate energy-charge regulation.
Reason: Directly describes the metabolism of the enzyme's substrate; well supported by the catalytic activity and by the phylogenetic inference.
Supporting Evidence:
file:human/AMPD1/AMPD1-uniprot.txt
Reaction=AMP + H2O + H(+) = IMP + NH4(+)
|
|
GO:0003876
AMP deaminase activity
|
IEA
GO_REF:0000120 |
ACCEPT |
Summary: Electronic assertion of the core AMP deaminase activity (via mouse ortholog, InterPro AMPD signature, RHEA:14777 and EC 3.5.4.6). Consistent with the experimental human evidence.
Reason: Correct molecular function; redundant with the experimental and IBA calls but appropriately mapped.
Supporting Evidence:
file:human/AMPD1/AMPD1-uniprot.txt
Reaction=AMP + H2O + H(+) = IMP + NH4(+)
|
|
GO:0006753
nucleoside phosphate metabolic process
|
IEA
GO_REF:0000117 |
KEEP AS NON CORE |
Summary: Very general parent process (AMP and IMP are nucleoside phosphates), so the annotation is correct but uninformative relative to the specific AMP/IMP terms already present.
Reason: Correct but high-level ARBA electronic annotation; superseded in specificity by GO:0046033 (AMP metabolic process) and GO:0032264 (IMP salvage).
Supporting Evidence:
file:human/AMPD1/AMPD1-uniprot.txt
Reaction=AMP + H2O + H(+) = IMP + NH4(+)
|
|
GO:0009168
purine ribonucleoside monophosphate biosynthetic process
|
IEA
GO_REF:0000002 |
KEEP AS NON CORE |
Summary: InterPro2GO electronic mapping. AMPD1 produces the purine ribonucleoside monophosphate IMP from AMP, so the biosynthetic framing is broadly correct, but AMP salvage/catabolism to IMP (GO:0032264) captures the enzyme's role more precisely.
Reason: Broadly correct generic IEA; the enzyme's actual step is better described by IMP salvage / AMP metabolism, which are already annotated.
Supporting Evidence:
file:human/AMPD1/AMPD1-uniprot.txt
Purine metabolism; IMP biosynthesis via salvage pathway
|
|
GO:0019239
deaminase activity
|
IEA
GO_REF:0000002 |
MODIFY |
Summary: InterPro2GO mapping to the generic parent term. The specific and correct molecular function is AMP deaminase activity (GO:0003876), already annotated with experimental support.
Reason: Too general; AMPD1 specifically deaminates AMP. Replace with the child term AMP deaminase activity.
Proposed replacements:
AMP deaminase activity
Supporting Evidence:
file:human/AMPD1/AMPD1-uniprot.txt
Reaction=AMP + H2O + H(+) = IMP + NH4(+)
|
|
GO:0032264
IMP salvage
|
IEA
GO_REF:0000120 |
ACCEPT |
Summary: AMPD1 forms IMP directly from AMP; UniProt/UniPathway annotate this as "IMP biosynthesis via salvage pathway; IMP from AMP: step 1/1" (UPA00591). This is the precise process for the enzyme's product-forming reaction.
Reason: Directly matches the enzyme's committed step (AMP -> IMP), the most informative process term for AMPD1.
Supporting Evidence:
file:human/AMPD1/AMPD1-uniprot.txt
Purine metabolism; IMP biosynthesis via salvage pathway
|
|
GO:0005515
protein binding
|
IPI
PMID:32296183 A reference map of the human binary protein interactome. |
MARK AS OVER ANNOTATED |
Summary: Bare "protein binding" from the human binary interactome (HuRI, IntAct). The captured interactions are AMPD1 with the paralogs AMPD2 (Q01433-2) and AMPD3 (Q01432-4). The term itself is uninformative about molecular function.
Reason: Experimental IPI, retained per curation policy (not removed), but the generic "protein binding" term conveys no specific function. The biologically meaningful oligomerisation is captured by GO:0042802 (identical protein binding), matching the documented homotetramer.
Supporting Evidence:
file:human/AMPD1/AMPD1-uniprot.txt
AMPD3; NbExp=3
|
|
GO:0042802
identical protein binding
|
IPI
PMID:32296183 A reference map of the human binary protein interactome. |
ACCEPT |
Summary: AMPD1 self-interaction detected in the human binary interactome, matching the well-established homotetrameric quaternary structure of AMP deaminase.
Reason: Consistent with the documented homotetramer; a biologically meaningful self-association annotation.
Supporting Evidence:
file:human/AMPD1/AMPD1-uniprot.txt
Homotetramer.
|
|
GO:0005829
cytosol
|
TAS
Reactome:R-HSA-76590 |
ACCEPT |
Summary: AMP deaminase is a cytosolic enzyme. Reactome curates the AMPD reaction (AMP + H2O => IMP + NH4+) in the cytosol; in skeletal muscle AMPD1 is classically associated with the myofibrillar/contractile apparatus.
Reason: Correct subcellular localisation, consistent with Reactome and the enzyme's role in cytosolic purine nucleotide metabolism.
Supporting Evidence:
Reactome:R-HSA-76590
Cytosolic AMP deaminase (AMPD) catalyzes the hydrolysis of AMP to yield IMP and ammonia.
|
|
GO:0003876
AMP deaminase activity
|
ISS
GO_REF:0000024 |
ACCEPT |
Summary: Sequence-similarity transfer of AMP deaminase activity from the rat ortholog (P10759). Correct and concordant with the experimental human evidence.
Reason: Correct core molecular function; ISS transfer is appropriate for this well-conserved enzyme.
Supporting Evidence:
file:human/AMPD1/AMPD1-uniprot.txt
Reaction=AMP + H2O + H(+) = IMP + NH4(+)
|
|
GO:0003876
AMP deaminase activity
|
IMP
PMID:11102975 First missense mutations (R388W and R425H) of AMPD1 accompan... |
ACCEPT |
Summary: Direct human functional evidence. The MMDD missense variants R388W and R425H, expressed recombinantly, produced comparable amounts of AMPD1 protein but had undetectable AMP deaminase activity, confirming that AMPD1 enables AMP deaminase activity and that its loss causes myopathy.
Reason: Loss-of-function mutations abolishing AMPD activity provide strong experimental support for this being the enzyme's core molecular function.
Supporting Evidence:
PMID:11102975
undetectable AMPD activity in the
PMID:11102975
AMPD1 indeed has a key role in muscle metabolism
|
|
GO:0032263
GMP salvage
|
IDA
PMID:29079593 Hypoxia modulates the purine salvage pathway and decreases r... |
MARK AS OVER ANNOTATED |
Summary: This annotation derives from a red-blood-cell storage metabolomics study of the purine salvage/deamination pathway. AMP deaminase acts on AMP to make IMP + ammonia and does not act on guanine nucleotides, so "GMP salvage" is a pathway-level co-annotation rather than a direct function of AMPD1.
Reason: Experimental IDA, retained per curation policy (not removed), but GMP salvage is not the direct biochemistry of AMP deaminase; the enzyme's role is in the AMP -> IMP branch, better captured by GO:0032264 IMP salvage and GO:0046033 AMP metabolic process.
Supporting Evidence:
PMID:29079593
purine salvage pathway
|
|
GO:0032263
GMP salvage
|
IDA
PMID:29079593 Hypoxia modulates the purine salvage pathway and decreases r... |
MARK AS OVER ANNOTATED |
Summary: Duplicate GMP salvage annotation (involved_in qualifier) from the same RBC storage metabolomics study. As above, AMP deaminase does not act on guanine nucleotides; this is a pathway-level co-annotation, not AMPD1's direct function.
Reason: Experimental IDA retained per policy, but not the enzyme's direct process; the AMP -> IMP step is captured by IMP salvage and AMP metabolic process.
Supporting Evidence:
PMID:29079593
purine salvage pathway
|
|
GO:0003876
AMP deaminase activity
|
TAS
PMID:644316 Myoadenylate deaminase deficiency: a new disease of muscle. |
ACCEPT |
Summary: Author statement supporting AMP deaminase (adenylate deaminase) activity as the muscle enzyme whose deficiency defines myoadenylate deaminase deficiency. Fishbein et al. showed patient muscle biopsies lacked adenylate deaminase by stain and solution assay.
Reason: Consistent with the core molecular function; the foundational clinical description linking loss of muscle AMP deaminase activity to disease.
Supporting Evidence:
PMID:644316
lacked adenylate deaminase by
|
Gene: AMPD1 (AMP deaminase 1, muscle isoform "M" / myoadenylate deaminase)
UniProt: P23109 (human), 747 aa, EC 3.5.4.6
HGNC:468; taxon NCBITaxon:9606
Falcon deep research was OUT OF CREDITS (HTTP 402) at review time; no
-deep-research-falcon.md was generated. Review grounded in
AMPD1-uniprot.txt, the seeded GOA (AMPD1-goa.tsv), and cached
publications/PMID_*.md + reactome/R-HSA-76590.md.
MF:
- GO:0003876 AMP deaminase activity — core MF. Supported experimentally
(IMP PMID:11102975: R388W/R425H abolish AMPD activity; TAS PMID:644316;
ISS from rat P10759; IBA; IEA). All ACCEPT (multiple redundant evidence
lines are fine).
- GO:0019239 deaminase activity (IEA, InterPro) — parent of GO:0003876; too
general -> MODIFY to GO:0003876.
- GO:0005515 protein binding (IPI x2, PMID:32296183/HuRI) — uninformative bare
term; interactions are AMPD1-AMPD2 and AMPD1-AMPD3 (IntAct). Do NOT REMOVE
(experimental IPI); MARK_AS_OVER_ANNOTATED per curation policy.
- GO:0042802 identical protein binding (IPI, PMID:32296183; with/from P23109
self) — corresponds to the real homotetramer (UniProt SUBUNIT). ACCEPT.
BP:
- GO:0046033 AMP metabolic process (IBA) — accurate, core substrate metabolism.
ACCEPT.
- GO:0032264 IMP salvage (IEA, UniPathway UPA00591) — matches UniProt PATHWAY
"IMP from AMP: step 1/1". ACCEPT (core; the direct product-forming process).
- GO:0006188 IMP biosynthetic process (IBA) — IMP is the product; reasonable,
though "salvage" (GO:0032264) is more precise. KEEP_AS_NON_CORE (accurate
but a de-novo-flavoured parent-ish framing; the salvage term is the precise
one). ACCEPT-level correctness but not the most precise; keep.
- GO:0009168 purine ribonucleoside monophosphate biosynthetic process (IEA,
InterPro) — generic biosynthetic framing; the reaction is better described
as AMP catabolism / IMP salvage. Keep as broadly correct IEA
(KEEP_AS_NON_CORE).
- GO:0006753 nucleoside phosphate metabolic process (IEA, ARBA) — very general
parent; correct but uninformative. KEEP_AS_NON_CORE.
- GO:0032263 GMP salvage (IDA, PMID:29079593, assigned by MGI) — PMID:29079593
is a red-blood-cell storage metabolomics study centred on the erythrocyte
purine salvage/deamination pathway (AMPD3 context). AMP deaminase produces
IMP + NH3 from AMP; it does not act on guanine nucleotides, so "GMP salvage"
is not the direct biochemistry of this enzyme. Experimental IDA -> do NOT
REMOVE per policy; MARK_AS_OVER_ANNOTATED (pathway-level co-annotation, not
AMPD1's direct function). Two rows (acts_upstream_of_or_within + involved_in)
both from same PMID.
CC:
- GO:0005829 cytosol (TAS, Reactome R-HSA-76590) — correct; AMPD is cytosolic.
ACCEPT.
id: P23109
gene_symbol: AMPD1
product_type: PROTEIN
status: INITIALIZED
taxon:
id: NCBITaxon:9606
label: Homo sapiens
description: >-
AMPD1 is the skeletal-muscle ("M") isoform of AMP deaminase, a cytosolic
zinc metalloenzyme that catalyses the hydrolytic deamination of AMP to IMP
and ammonia (AMP + H2O -> IMP + NH4+; EC 3.5.4.6). It is a homotetramer of
the metallo-dependent hydrolase superfamily (adenosine and AMP deaminase
family). In skeletal muscle AMPD1 performs the committed step of the purine
nucleotide cycle (AMP -> IMP by AMP deaminase; IMP -> adenylosuccinate by
adenylosuccinate synthase; adenylosuccinate -> AMP + fumarate by
adenylosuccinate lyase). By deaminating AMP, the enzyme pulls the adenylate
kinase equilibrium toward ATP regeneration and thereby buffers the cellular
energy charge during intense exercise, while the cycle also releases
fumarate for TCA-cycle anaplerosis and ammonia. It is the most highly
expressed AMP deaminase isoform in skeletal muscle (also expressed in
tongue). Loss-of-function of AMPD1 causes myoadenylate deaminase deficiency
(AMP deaminase deficiency; MMDD, MIM:615511), one of the most common
inherited metabolic muscle defects, which is frequently benign or
asymptomatic but can present with exercise-induced myalgia, cramps and
early fatigue.
alternative_products:
- name: '1'
id: P23109-1
- name: '2'
id: P23109-2
sequence_note: VSP_042638
existing_annotations:
- term:
id: GO:0003876
label: AMP deaminase activity
evidence_type: IBA
original_reference_id: GO_REF:0000033
qualifier: enables
review:
summary: >-
Core molecular function. AMPD1 hydrolytically deaminates AMP to IMP plus
ammonia (EC 3.5.4.6), the defining and experimentally established
activity of this enzyme. The phylogenetic (IBA) call is well supported
and consistent with direct human evidence.
action: ACCEPT
reason: >-
AMP deaminase activity is the primary, catalytically demonstrated
function of AMPD1. UniProt records the reaction and EC number with
experimental evidence, and disease-causing mutations abolish this
activity.
supported_by:
- reference_id: file:human/AMPD1/AMPD1-uniprot.txt
supporting_text: "Reaction=AMP + H2O + H(+) = IMP + NH4(+)"
- reference_id: PMID:11102975
supporting_text: "undetectable AMPD activity in the"
- term:
id: GO:0006188
label: IMP biosynthetic process
evidence_type: IBA
original_reference_id: GO_REF:0000033
qualifier: involved_in
review:
summary: >-
IMP is the direct product of AMPD1-catalysed AMP deamination, so
participation in IMP biosynthesis is correct. UniProt frames the pathway
as "IMP biosynthesis via salvage pathway; IMP from AMP: step 1/1", which
is captured more precisely by GO:0032264 IMP salvage.
action: KEEP_AS_NON_CORE
reason: >-
Accurate but less precise than the salvage-specific term; retained as a
correct broader process annotation rather than the core process framing.
supported_by:
- reference_id: file:human/AMPD1/AMPD1-uniprot.txt
supporting_text: "Purine metabolism; IMP biosynthesis via salvage pathway"
- term:
id: GO:0046033
label: AMP metabolic process
evidence_type: IBA
original_reference_id: GO_REF:0000033
qualifier: involved_in
review:
summary: >-
AMPD1 acts directly on AMP (its substrate), so participation in AMP
metabolic process is accurate and reflects the enzyme's role in the
purine nucleotide cycle and adenylate energy-charge regulation.
action: ACCEPT
reason: >-
Directly describes the metabolism of the enzyme's substrate; well
supported by the catalytic activity and by the phylogenetic inference.
supported_by:
- reference_id: file:human/AMPD1/AMPD1-uniprot.txt
supporting_text: "Reaction=AMP + H2O + H(+) = IMP + NH4(+)"
- term:
id: GO:0003876
label: AMP deaminase activity
evidence_type: IEA
original_reference_id: GO_REF:0000120
qualifier: enables
review:
summary: >-
Electronic assertion of the core AMP deaminase activity (via mouse
ortholog, InterPro AMPD signature, RHEA:14777 and EC 3.5.4.6). Consistent
with the experimental human evidence.
action: ACCEPT
reason: >-
Correct molecular function; redundant with the experimental and IBA calls
but appropriately mapped.
supported_by:
- reference_id: file:human/AMPD1/AMPD1-uniprot.txt
supporting_text: "Reaction=AMP + H2O + H(+) = IMP + NH4(+)"
- term:
id: GO:0006753
label: nucleoside phosphate metabolic process
evidence_type: IEA
original_reference_id: GO_REF:0000117
qualifier: involved_in
review:
summary: >-
Very general parent process (AMP and IMP are nucleoside phosphates), so
the annotation is correct but uninformative relative to the specific
AMP/IMP terms already present.
action: KEEP_AS_NON_CORE
reason: >-
Correct but high-level ARBA electronic annotation; superseded in
specificity by GO:0046033 (AMP metabolic process) and GO:0032264 (IMP
salvage).
supported_by:
- reference_id: file:human/AMPD1/AMPD1-uniprot.txt
supporting_text: "Reaction=AMP + H2O + H(+) = IMP + NH4(+)"
- term:
id: GO:0009168
label: purine ribonucleoside monophosphate biosynthetic process
evidence_type: IEA
original_reference_id: GO_REF:0000002
qualifier: involved_in
review:
summary: >-
InterPro2GO electronic mapping. AMPD1 produces the purine ribonucleoside
monophosphate IMP from AMP, so the biosynthetic framing is broadly
correct, but AMP salvage/catabolism to IMP (GO:0032264) captures the
enzyme's role more precisely.
action: KEEP_AS_NON_CORE
reason: >-
Broadly correct generic IEA; the enzyme's actual step is better described
by IMP salvage / AMP metabolism, which are already annotated.
supported_by:
- reference_id: file:human/AMPD1/AMPD1-uniprot.txt
supporting_text: "Purine metabolism; IMP biosynthesis via salvage pathway"
- term:
id: GO:0019239
label: deaminase activity
evidence_type: IEA
original_reference_id: GO_REF:0000002
qualifier: enables
review:
summary: >-
InterPro2GO mapping to the generic parent term. The specific and correct
molecular function is AMP deaminase activity (GO:0003876), already
annotated with experimental support.
action: MODIFY
reason: >-
Too general; AMPD1 specifically deaminates AMP. Replace with the child
term AMP deaminase activity.
proposed_replacement_terms:
- id: GO:0003876
label: AMP deaminase activity
supported_by:
- reference_id: file:human/AMPD1/AMPD1-uniprot.txt
supporting_text: "Reaction=AMP + H2O + H(+) = IMP + NH4(+)"
- term:
id: GO:0032264
label: IMP salvage
evidence_type: IEA
original_reference_id: GO_REF:0000120
qualifier: involved_in
review:
summary: >-
AMPD1 forms IMP directly from AMP; UniProt/UniPathway annotate this as
"IMP biosynthesis via salvage pathway; IMP from AMP: step 1/1"
(UPA00591). This is the precise process for the enzyme's product-forming
reaction.
action: ACCEPT
reason: >-
Directly matches the enzyme's committed step (AMP -> IMP), the most
informative process term for AMPD1.
supported_by:
- reference_id: file:human/AMPD1/AMPD1-uniprot.txt
supporting_text: "Purine metabolism; IMP biosynthesis via salvage pathway"
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:32296183
qualifier: enables
review:
summary: >-
Bare "protein binding" from the human binary interactome (HuRI, IntAct).
The captured interactions are AMPD1 with the paralogs AMPD2 (Q01433-2)
and AMPD3 (Q01432-4). The term itself is uninformative about molecular
function.
action: MARK_AS_OVER_ANNOTATED
reason: >-
Experimental IPI, retained per curation policy (not removed), but the
generic "protein binding" term conveys no specific function. The
biologically meaningful oligomerisation is captured by GO:0042802
(identical protein binding), matching the documented homotetramer.
supported_by:
- reference_id: file:human/AMPD1/AMPD1-uniprot.txt
supporting_text: "AMPD3; NbExp=3"
- term:
id: GO:0042802
label: identical protein binding
evidence_type: IPI
original_reference_id: PMID:32296183
qualifier: enables
review:
summary: >-
AMPD1 self-interaction detected in the human binary interactome, matching
the well-established homotetrameric quaternary structure of AMP deaminase.
action: ACCEPT
reason: >-
Consistent with the documented homotetramer; a biologically meaningful
self-association annotation.
supported_by:
- reference_id: file:human/AMPD1/AMPD1-uniprot.txt
supporting_text: "Homotetramer."
- term:
id: GO:0005829
label: cytosol
evidence_type: TAS
original_reference_id: Reactome:R-HSA-76590
qualifier: located_in
review:
summary: >-
AMP deaminase is a cytosolic enzyme. Reactome curates the AMPD reaction
(AMP + H2O => IMP + NH4+) in the cytosol; in skeletal muscle AMPD1 is
classically associated with the myofibrillar/contractile apparatus.
action: ACCEPT
reason: >-
Correct subcellular localisation, consistent with Reactome and the
enzyme's role in cytosolic purine nucleotide metabolism.
supported_by:
- reference_id: Reactome:R-HSA-76590
supporting_text: "Cytosolic AMP deaminase (AMPD) catalyzes the hydrolysis of AMP to yield IMP and ammonia."
- term:
id: GO:0003876
label: AMP deaminase activity
evidence_type: ISS
original_reference_id: GO_REF:0000024
qualifier: enables
review:
summary: >-
Sequence-similarity transfer of AMP deaminase activity from the rat
ortholog (P10759). Correct and concordant with the experimental human
evidence.
action: ACCEPT
reason: >-
Correct core molecular function; ISS transfer is appropriate for this
well-conserved enzyme.
supported_by:
- reference_id: file:human/AMPD1/AMPD1-uniprot.txt
supporting_text: "Reaction=AMP + H2O + H(+) = IMP + NH4(+)"
- term:
id: GO:0003876
label: AMP deaminase activity
evidence_type: IMP
original_reference_id: PMID:11102975
qualifier: enables
review:
summary: >-
Direct human functional evidence. The MMDD missense variants R388W and
R425H, expressed recombinantly, produced comparable amounts of AMPD1
protein but had undetectable AMP deaminase activity, confirming that
AMPD1 enables AMP deaminase activity and that its loss causes myopathy.
action: ACCEPT
reason: >-
Loss-of-function mutations abolishing AMPD activity provide strong
experimental support for this being the enzyme's core molecular function.
supported_by:
- reference_id: PMID:11102975
supporting_text: "undetectable AMPD activity in the"
- reference_id: PMID:11102975
supporting_text: "AMPD1 indeed has a key role in muscle metabolism"
- term:
id: GO:0032263
label: GMP salvage
evidence_type: IDA
original_reference_id: PMID:29079593
qualifier: acts_upstream_of_or_within
review:
summary: >-
This annotation derives from a red-blood-cell storage metabolomics study
of the purine salvage/deamination pathway. AMP deaminase acts on AMP to
make IMP + ammonia and does not act on guanine nucleotides, so "GMP
salvage" is a pathway-level co-annotation rather than a direct function
of AMPD1.
action: MARK_AS_OVER_ANNOTATED
reason: >-
Experimental IDA, retained per curation policy (not removed), but GMP
salvage is not the direct biochemistry of AMP deaminase; the enzyme's
role is in the AMP -> IMP branch, better captured by GO:0032264 IMP
salvage and GO:0046033 AMP metabolic process.
supported_by:
- reference_id: PMID:29079593
supporting_text: "purine salvage pathway"
- term:
id: GO:0032263
label: GMP salvage
evidence_type: IDA
original_reference_id: PMID:29079593
qualifier: involved_in
review:
summary: >-
Duplicate GMP salvage annotation (involved_in qualifier) from the same
RBC storage metabolomics study. As above, AMP deaminase does not act on
guanine nucleotides; this is a pathway-level co-annotation, not AMPD1's
direct function.
action: MARK_AS_OVER_ANNOTATED
reason: >-
Experimental IDA retained per policy, but not the enzyme's direct process;
the AMP -> IMP step is captured by IMP salvage and AMP metabolic process.
supported_by:
- reference_id: PMID:29079593
supporting_text: "purine salvage pathway"
- term:
id: GO:0003876
label: AMP deaminase activity
evidence_type: TAS
original_reference_id: PMID:644316
qualifier: enables
review:
summary: >-
Author statement supporting AMP deaminase (adenylate deaminase) activity
as the muscle enzyme whose deficiency defines myoadenylate deaminase
deficiency. Fishbein et al. showed patient muscle biopsies lacked
adenylate deaminase by stain and solution assay.
action: ACCEPT
reason: >-
Consistent with the core molecular function; the foundational clinical
description linking loss of muscle AMP deaminase activity to disease.
supported_by:
- reference_id: PMID:644316
supporting_text: "lacked adenylate deaminase by"
core_functions:
- description: >-
Cytosolic AMP deaminase catalysing the hydrolytic deamination of AMP to IMP
and ammonia (EC 3.5.4.6), the committed step of the skeletal-muscle purine
nucleotide cycle.
molecular_function:
id: GO:0003876
label: AMP deaminase activity
directly_involved_in:
- id: GO:0032264
label: IMP salvage
locations:
- id: GO:0005829
label: cytosol
supported_by:
- reference_id: PMID:11102975
supporting_text: "undetectable AMPD activity in the"
- reference_id: file:human/AMPD1/AMPD1-uniprot.txt
supporting_text: "Purine metabolism; IMP biosynthesis via salvage pathway"
- description: >-
By deaminating AMP, AMPD1 drives adenine-nucleotide (AMP) metabolism in
muscle, pulling the adenylate kinase equilibrium toward ATP regeneration
and buffering the cellular energy charge during intense exercise.
molecular_function:
id: GO:0003876
label: AMP deaminase activity
directly_involved_in:
- id: GO:0046033
label: AMP metabolic process
locations:
- id: GO:0005829
label: cytosol
supported_by:
- reference_id: file:human/AMPD1/AMPD1-uniprot.txt
supporting_text: "AMP deaminase plays a critical role in energy metabolism."
references:
- id: GO_REF:0000002
title: Gene Ontology annotation through association of InterPro records with GO
terms
findings: []
- id: GO_REF:0000024
title: Manual transfer of experimentally-verified manual GO annotation data to orthologs
by curator judgment of sequence similarity
findings: []
- id: GO_REF:0000033
title: Annotation inferences using phylogenetic trees
findings: []
- id: GO_REF:0000117
title: Electronic Gene Ontology annotations created by ARBA machine learning models
findings: []
- id: GO_REF:0000120
title: Combined Automated Annotation using Multiple IEA Methods
findings: []
- id: PMID:11102975
title: First missense mutations (R388W and R425H) of AMPD1 accompanied with myopathy
found in a Japanese patient.
findings:
- statement: >-
The MMDD missense variants R388W and R425H produced comparable amounts of
AMPD1 protein on recombinant expression but had undetectable AMP deaminase
activity, establishing AMPD1's core catalytic function and its role in
muscle metabolism.
supporting_text: "undetectable AMPD activity in the"
reference_review:
relevance: HIGH
correctness: VERIFIED
review_notes: >-
Abstract-only cache; title and abstract match PubMed 11102975. Directly
establishes AMPD1 AMP deaminase activity and disease link via
loss-of-function variants.
- id: PMID:29079593
title: Hypoxia modulates the purine salvage pathway and decreases red blood cell
and supernatant levels of hypoxanthine during refrigerated storage.
findings:
- statement: >-
Study of hypoxia and refrigerated storage effects on the red-blood-cell
purine salvage/deamination pathway; source of an MGI GMP salvage
annotation that is a pathway-level co-annotation rather than a direct AMP
deaminase function.
supporting_text: "purine salvage pathway"
reference_review:
relevance: LOW
correctness: MISCITED
review_notes: >-
Full-text available. The paper concerns erythrocyte purine
salvage/deamination during RBC storage; AMP deaminase acts on AMP (not
guanine nucleotides), so the derived "GMP salvage" annotation does not
reflect AMPD1's direct biochemistry (marked over-annotated, not removed
per policy on experimental annotations).
- id: PMID:32296183
title: A reference map of the human binary protein interactome.
findings:
- statement: >-
Human binary interactome (HuRI) map; source of AMPD1 protein-protein
interaction annotations, including self-association consistent with the
homotetramer and interactions with paralogs AMPD2 and AMPD3.
supporting_text: "reference map of the human binary protein interactome"
reference_review:
relevance: MEDIUM
correctness: VERIFIED
review_notes: >-
Large-scale interactome resource. Supports identical protein binding
(homotetramer); the bare "protein binding" rows are uninformative and
marked over-annotated.
- id: PMID:644316
title: 'Myoadenylate deaminase deficiency: a new disease of muscle.'
findings:
- statement: >-
Foundational clinical description of myoadenylate deaminase deficiency:
patients with exercise-induced muscle weakness/cramping whose biopsies
lacked adenylate deaminase activity, defining loss of muscle AMP deaminase
as a distinct muscle disease.
supporting_text: "lacked adenylate deaminase by"
reference_review:
relevance: HIGH
correctness: VERIFIED
review_notes: >-
Abstract-only cache; title/abstract match PubMed 644316. Establishes the
disease phenotype associated with loss of muscle AMP deaminase activity.
- id: Reactome:R-HSA-76590
title: AMP + H2O => IMP + NH4+ (AMPD)
findings:
- statement: >-
Reactome reaction placing cytosolic AMP deaminase (AMPD) catalysis of
AMP + H2O => IMP + NH4+ in the cytosol.
supporting_text: "Cytosolic AMP deaminase (AMPD) catalyzes the hydrolysis of AMP to yield IMP and ammonia."